Dr. Namita Khanna

Dr. Sand earned his medical degree from the University of North Carolina's School of Medicine where he graduated with Honors. He completed his surgical internship and residency in Urology at New York University Medical Center. He received his undergraduate degree in Microbiology from the University of Georgia, graduating with First Honor status. Prior to joining Piedmont Physicians Urology Specialists, Dr. Sand was the Chief Resident in Urology at the New York University Medical Center where he trained with national experts in prostate cancer, Robotic Surgery, Urologic stone disease, and Female Urologic disorders. He is board certified in urology. Dr. Sand's interests include treating patients with low testosterone, erectile dysfunction, stone disease and voiding dysfunction including male and female urinary incontinence. In his spare time, Dr. Sand enjoys spending time with his family, traveling and is also an avid college football fan. Dr. Sand strives to treat the patient as a whole and works with his patients to develop treatment plans that maximize efficacy and patient satisfaction. Dr. Sand welcomes new patients and accepts most major insurance plans. Dr. Sand is rated as a Distinguished provider by MediFind in the treatment of Hydrocele. His top areas of expertise are Bilateral Hydronephrosis, Hydronephrosis, Obstructive Uropathy, Ureteroscopy, and Prostatectomy.

Dr. Leda Gattoc is a Gynecologic Oncologist at Piedmont Healthcare. She earned her medical degree at New York University in New York City and completed her residency in Obstetrics and Gynecology at Long Island Jewish Hospital in New Hyde Park, NY. After residency, she completed a Pelvic Surgery Fellowship at Emory University where she also obtained her degree in Master of Science in Clinical Research. Dr. Gattoc then went on to complete her fellowship in Gynecologic Oncology at Wayne StateUniversity/ Karmanos Cancer Institute in Detroit, Michigan.Dr. Gattoc is board certified in both Gynecologic Oncology and Obstetrics and Gynecology. She also has a designated practitioner certification in Minimally Invasive Gynecologic Surgery. She is a member of the Society of Gynecologic Oncology, American College of Obstetricians & Gynecologists and American Association of Gynecologic Laparoscopists. Dr. Gattoc is dedicated to providing high quality, personalized care to women with gynecologic cancers utilizing both surgery and chemotherapy. She has a special interest in pre-invasive diseases, minimally invasive robotic and laparoscopic surgeries and complex benign gynecologic conditions. She is fluent in English, Spanish and Tagalog. Dr. Gattoc is accepting new patients and welcomes most major insurance plans. Dr. Gattoc is rated as an Advanced provider by MediFind in the treatment of Hydrocele. Her top areas of expertise are Lump in the Abdomen, Malignant Mixed Mullerian Tumor, Endometrial Cancer, Endometrial Stromal Sarcoma, and Hysterectomy.

Cyril O. Spann, Jr., M.D., joins Piedmont from Emory Healthcare. He is board certified in Gynecologic Oncology and graduated from Meharry Medical College in Nashville, TN. Dr. Spann has over 30 years of experience in gynecology and gynecologic oncology. During his time at Emory, he served as Chief of the Gynecologic Oncology Service at both Emory Midtown and Grady Hospital. Dr. Spann is a member of the American Board of Obstetrics & Gynecology and is a Diplomate for the American Board of Quality Assurance Utilization Review Physicians. Prior to joining Piedmont, Dr. Spann served as president of the Atlanta Medical Association and the Georgia OBGYN Society.Dr. Spann specializes in managing patients with cancer in the female reproductive tract. He has a surgical interest in robot/laparoscopic minimal invasive surgery.In his spare time, Dr. Spann enjoys hiking, bicycling, reading and travel.Dr. Spann welcomes new patients and accepts most insurance plans. Dr. Spann is rated as a Distinguished provider by MediFind in the treatment of Hydrocele. His top areas of expertise are Endometrial Cancer, Endometrial Stromal Sarcoma, Malignant Mixed Mullerian Tumor, Bladder Reconstruction, and Oophorectomy.